51
|
Shimizu M, Taomoto Y, Amemiya M, Yamakami Y, Sato Y, Iiya M, Nakamura R, Nakano K, Shimada H, Fujii H, Yamawake N, Nishizaki M, Sakurada H, Hiraoka M. P1458Prognostic value of T wave axis deviation for left ventricular dysfunction in patients with complete left bundle branch block. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p1458] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
52
|
Aidala C, Ajitanand N, Akiba Y, Akimoto R, Alexander J, Alfred M, Aoki K, Apadula N, Asano H, Atomssa E, Awes T, Ayuso C, Azmoun B, Babintsev V, Bagoly A, Bai M, Bai X, Bannier B, Barish K, Bathe S, Baublis V, Baumann C, Baumgart S, Bazilevsky A, Beaumier M, Belmont R, Berdnikov A, Berdnikov Y, Black D, Blau D, Boer M, Bok J, Boyle K, Brooks M, Bryslawskyj J, Buesching H, Bumazhnov V, Butler C, Butsyk S, Campbell S, Canoa Roman V, Chen CH, Chi C, Chiu M, Choi I, Choi J, Choi S, Christiansen P, Chujo T, Cianciolo V, Cole B, Connors M, Cronin N, Crossette N, Csanád M, Csörgő T, Danley T, Datta A, Daugherity M, David G, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond E, Ding L, Do J, D’Orazio L, Drapier O, Drees A, Drees K, Dumancic M, Durham J, Durum A, Elder T, Engelmore T, Enokizono A, Esumi S, Eyser K, Fadem B, Fan W, Feege N, Fields D, Finger M, Finger M, Fleuret F, Fokin S, Frantz J, Franz A, Frawley A, Fukao Y, Fukuda Y, Fusayasu T, Gainey K, Gal C, Garg P, Garishvili A, Garishvili I, Ge H, Giordano F, Glenn A, Gong X, Gonin M, Goto Y, Granier de Cassagnac R, Grau N, Greene S, Grosse Perdekamp M, Gu Y, Gunji T, Guragain H, Hachiya T, Haggerty J, Hahn K, Hamagaki H, Han S, Hanks J, Hasegawa S, Haseler T, Hashimoto K, Hayano R, He X, Hemmick T, Hester T, Hill J, Hill K, Hollis R, Homma K, Hong B, Hoshino T, Hotvedt N, Huang J, Huang S, Ichihara T, Ikeda Y, Imai K, Imazu Y, Imrek J, Inaba M, Iordanova A, Isenhower D, Isinhue A, Ito Y, Ivanishchev D, Jacak B, Jeon S, Jezghani M, Ji Z, Jia J, Jiang X, Johnson B, Joo K, Jorjadze V, Jouan D, Jumper D, Kamin J, Kanda S, Kang B, Kang J, Kang J, Kapukchyan D, Kapustinsky J, Karthas S, Kawall D, Kazantsev A, Key J, Khachatryan V, Khandai P, Khanzadeev A, Kijima K, Kim C, Kim D, Kim EJ, Kim M, Kim M, Kim YJ, Kim Y, Kincses D, Kistenev E, Klatsky J, Kleinjan D, Kline P, Koblesky T, Kofarago M, Komkov B, Koster J, Kotchetkov D, Kotov D, Krizek F, Kudo S, Kurita K, Kurosawa M, Kwon Y, Lacey R, Lai Y, Lajoie J, Lallow E, Lebedev A, Lee D, Lee G, Lee J, Lee K, Lee K, Lee S, Leitch M, Leitgab M, Leung Y, Lewis B, Lewis N, Li X, Li X, Lim S, Liu L, Liu M, Loggins VR, Lokos S, Lynch D, Maguire C, Majoros T, Makdisi Y, Makek M, Malaev M, Manion A, Manko V, Mannel E, Masuda H, McCumber M, McGaughey P, McGlinchey D, McKinney C, Meles A, Mendoza M, Meredith B, Metzger W, Miake Y, Mibe T, Mignerey A, Mihalik D, Milov A, Mishra D, Mitchell J, Mitsuka G, Miyasaka S, Mizuno S, Mohanty A, Mohapatra S, Moon T, Morrison D, Morrow S, Moskowitz M, Moukhanova T, Murakami T, Murata J, Mwai A, Nagae T, Nagai K, Nagamiya S, Nagashima K, Nagashima T, Nagle J, Nagy M, Nakagawa I, Nakagomi H, Nakamiya Y, Nakamura K, Nakamura T, Nakano K, Nattrass C, Netrakanti P, Nihashi M, Niida T, Nouicer R, Novák T, Novitzky N, Novotny R, Nyanin A, O’Brien E, Ogilvie C, Oide H, Okada K, Orjuela Koop J, Osborn J, Oskarsson A, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park I, Park J, Park S, Park S, Pate S, Patel L, Patel M, Peng JC, Peng W, Perepelitsa D, Perera G, Peressounko D, PerezLara C, Perry J, Petti R, Phipps M, Pinkenburg C, Pisani R, Pun A, Purschke M, Qu H, Radzevich P, Rak J, Ravinovich I, Read K, Reynolds D, Riabov V, Riabov Y, Richardson E, Richford D, Rinn T, Riveli N, Roach D, Rolnick S, Rosati M, Rowan Z, Runchey J, Ryu M, Sahlmueller B, Saito N, Sakaguchi T, Sako H, Samsonov V, Sarsour M, Sato K, Sato S, Sawada S, Schaefer B, Schmoll B, Sedgwick K, Seele J, Seidl R, Sekiguchi Y, Sen A, Seto R, Sett P, Sexton A, Sharma D, Shaver A, Shein I, Shibata TA, Shigaki K, Shimomura M, Shoji K, Shukla P, Sickles A, Silva C, Silvermyr D, Singh B, Singh C, Singh V, Skoby M, Skolnik M, Slunečka M, Smith K, Solano S, Soltz R, Sondheim W, Sorensen S, Sourikova I, Stankus P, Steinberg P, Stenlund E, Stepanov M, Ster A, Stoll S, Stone M, Sugitate T, Sukhanov A, Sun J, Syed S, Takahara A, Takeda A, Taketani A, Tanaka Y, Tanida K, Tannenbaum M, Tarafdar S, Taranenko A, Tarnai G, Tennant E, Tieulent R, Timilsina A, Todoroki T, Tomášek M, Torii H, Towell C, Towell R, Tserruya I, Ueda Y, Ujvari B, van Hecke H, Vargyas M, Vazquez-Carson S, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Virius M, Vrba V, Vznuzdaev E, Wang X, Wang Z, Watanabe D, Watanabe K, Watanabe Y, Watanabe Y, Wei F, Whitaker S, Wolin S, Wong C, Woody C, Wysocki M, Xia B, Xu C, Xu Q, Yamaguchi Y, Yanovich A, Yin P, Yokkaichi S, Yoo J, Yoon I, You Z, Younus I, Yu H, Yushmanov I, Zajc W, Zelenski A, Zharko S, Zhou S, Zou L. Cross section and transverse single-spin asymmetry of muons from open heavy-flavor decays in polarized
p+p
collisions at
s=200 GeV. Int J Clin Exp Med 2017. [DOI: 10.1103/physrevd.95.112001] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
53
|
Akioka K, Ishikawa T, Osaka M, Kadotani Y, Okugawa K, Nakano K, Osaka Y, Tsuchiya K, Sako H. Hyperuricemia and Acute Renal Failure in Renal Transplant Recipients Treated With High-Dose Mizoribine. Transplant Proc 2017; 49:73-77. [PMID: 28104163 DOI: 10.1016/j.transproceed.2016.11.015] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND Hyperuricemia is a common adverse event frequently found in renal transplant recipients with mizoribine (MZ). Hyperuricemia itself will be a cause of renal dysfunction, and renal dysfunction also will be a cause of hyperuricemia simultaneously. This study investigates frequency of hyperuricemia and renal failure in renal transplant recipients treated with high-dose MZ. PATIENTS AND METHODS From December 2007 to October 2015, there was a total of 32 living related renal transplant recipients treated with high-dose MZ. Of the 32 patients, 28 were treated with urate-lowering medications. RESULTS One patient received allopurinol (AP) and 13 patients received benzbromarone (BB). For 6 of them, their urate-lowering medications were converted to febuxostat (FX) form AP or BB. In the remaining 14 patients, FX was administered from the beginning. In 2 cases of ABO-incompatible living related renal transplant recipients who were maintained with high-dose MZ and BB, severe hyperuricemia and acute renal failure occurred. One patient was a 48-year-old man, and his creatinine (Cr) level increased to 8.14 mg/dL and his serum uric acid (UA) was 24.6 mg/dL. Another patient was a 57-year-old man, and his Cr level increased to 3.59 mg/dL and his UA was 13.2 mg/dL. In both cases Cr and UA were improved, and no finding of acute rejection and drug toxicity was observed in graft biopsy specimens. BB was switched to FX and discontinuance or reduction of MZ was done. CONCLUSION Combination of MZ and BB has the risk of acute renal dysfunction after renal transplantation. Latent renal dysfunction should be watched for in renal transplant recipients receiving high-dose MZ.
Collapse
|
54
|
Yamaguchi R, Osumi A, Onuma A, Nakano K, Maruyama S, Mitani T, Kato T, Okumura H, Matsumoto Y. Effects of Al addition to Si-based flux on the growth of 4H-SiC films by vapour–liquid–solid pulsed laser deposition. CrystEngComm 2017. [DOI: 10.1039/c7ce00945c] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
High-speed growth of 4H-SiC films by VLS-PLD with Si/Al flux at a growth temperature lower than 1300 °C.
Collapse
|
55
|
Adare A, Aidala C, Ajitanand N, Akiba Y, Akimoto R, Alfred M, Apadula N, Aramaki Y, Asano H, Atomssa E, Awes T, Azmoun B, Babintsev V, Bai M, Bandara N, Bannier B, Barish K, Bathe S, Bazilevsky A, Beaumier M, Beckman S, Belmont R, Berdnikov A, Berdnikov Y, Black D, Blau D, Bok J, Boyle K, Brooks M, Bryslawskyj J, Buesching H, Bumazhnov V, Campbell S, Chen CH, Chi C, Chiu M, Choi I, Choi J, Chujo T, Citron Z, Csanád M, Csörgő T, Danley T, Datta A, Daugherity M, David G, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond E, Ding L, Dion A, Diss P, Do J, Drees A, Drees K, Durham J, Durum A, Enokizono A, En’yo H, Esumi S, Fadem B, Feege N, Fields D, Finger M, Finger M, Fokin S, Frantz J, Franz A, Frawley A, Gal C, Gallus P, Garg P, Ge H, Giordano F, Glenn A, Goto Y, Grau N, Greene S, Grosse Perdekamp M, Gu Y, Gunji T, Guragain H, Hachiya T, Haggerty J, Hahn K, Hamagaki H, Hamilton H, Han S, Hanks J, Hasegawa S, Haseler T, Hashimoto K, He X, Hemmick T, Hill J, Hollis R, Homma K, Hong B, Hoshino T, Hotvedt N, Huang J, Huang S, Ikeda Y, Imai K, Imazu Y, Inaba M, Iordanova A, Isenhower D, Ivanishchev D, Jacak B, Jeon S, Jezghani M, Jia J, Jiang X, Johnson B, Joo E, Joo K, Jouan D, Jumper D, Kanda S, Kang J, Kang J, Kawall D, Kazantsev A, Key J, Khachatryan V, Khanzadeev A, Kihara K, Kim C, Kim D, Kim D, Kim EJ, Kim G, Kim HJ, Kim M, Kim Y, Kimelman B, Kistenev E, Kitamura R, Klatsky J, Kleinjan D, Kline P, Koblesky T, Kofarago M, Komkov B, Koster J, Kotov D, Kurita K, Kurosawa M, Kwon Y, Lacey R, Lajoie J, Lebedev A, Lee K, Lee S, Lee S, Leitch M, Leitgab M, Li X, Lim S, Liu M, Lynch D, Makdisi Y, Makek M, Manion A, Manko V, Mannel E, McCumber M, McGaughey P, McGlinchey D, McKinney C, Meles A, Mendoza M, Meredith B, Miake Y, Mignerey A, Miller A, Milov A, Mishra D, Mitchell J, Miyasaka S, Mizuno S, Mohanty A, Montuenga P, Moon T, Morrison D, Moukhanova T, Murakami T, Murata J, Mwai A, Nagamiya S, Nagashima K, Nagle J, Nagy M, Nakagawa I, Nakagomi H, Nakano K, Nattrass C, Netrakanti P, Nihashi M, Niida T, Nishimura S, Nouicer R, Novák T, Novitzky N, Nyanin A, O’Brien E, Ogilvie C, Orjuela Koop J, Osborn J, Oskarsson A, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park J, Park S, Pate S, Patel L, Patel M, Peng JC, Perepelitsa D, Perera G, Peressounko D, Perry J, Petti R, Pinkenburg C, Pinson R, Pisani R, Purschke M, Rak J, Ramson B, Ravinovich I, Read K, Reynolds D, Riabov V, Riabov Y, Rinn T, Riveli N, Roach D, Rolnick S, Rosati M, Rowan Z, Rubin J, Sahlmueller B, Saito N, Sakaguchi T, Sako H, Samsonov V, Sarsour M, Sato S, Sawada S, Schaefer B, Schmoll B, Sedgwick K, Seele J, Seidl R, Sen A, Seto R, Sett P, Sexton A, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shukla P, Sickles A, Silva C, Silvermyr D, Singh B, Singh C, Singh V, Slunečka M, Snowball M, Soltz R, Sondheim W, Sorensen S, Sourikova I, Stankus P, Stepanov M, Stoll S, Sugitate T, Sukhanov A, Sumita T, Sun J, Sziklai J, Takahara A, Taketani A, Tanida K, Tannenbaum M, Tarafdar S, Taranenko A, Tieulent R, Timilsina A, Todoroki T, Tomášek M, Torii H, Towell C, Towell M, Towell R, Towell R, Tserruya I, van Hecke H, Vargyas M, Velkovska J, Virius M, Vrba V, Vznuzdaev E, Wang X, Watanabe D, Watanabe Y, Watanabe Y, Wei F, Whitaker S, White A, Wolin S, Woody C, Wysocki M, Xia B, Xue L, Yalcin S, Yamaguchi Y, Yanovich A, Yoo J, Yoon I, Younus I, Yu H, Yushmanov I, Zajc W, Zelenski A, Zhou S, Zou L. Measurements of double-helicity asymmetries in inclusive
J/ψ
production in longitudinally polarized
p+p
collisions at
s=510
GeV. Int J Clin Exp Med 2016. [DOI: 10.1103/physrevd.94.112008] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
56
|
Marshall S, Nakano K, Taira S, Sugiura Y, Tomomatsu J, Takahashi S. 513P Dose of doxorubicin and outcome for advanced or metastatic soft tissue sarcoma of non-extremities. Ann Oncol 2016. [DOI: 10.1016/s0923-7534(21)00671-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
57
|
Marshall S, Nakano K, Taira S, Sugiura Y, Tomomatsu J, Takahashi S. 513P Dose of doxorubicin and outcome for advanced or metastatic soft tissue sarcoma of non-extremities. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw597.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
58
|
Nakano K, Marshall S, Taira S, Sato Y, Tomomatsu J, Sasaki T, Shimbashi W, Fukushima H, Yonekawa H, Mitani H, Kawabata K, Takahashi S. A comparison of cetuximab-containing regimens for recurrent/metastatic squamous cell head and neck carcinoma: the clinical significance of weekly paclitaxel and cetuximab. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw376.55] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
59
|
Hoki M, Watanabe K, Nakano K. MON-P138: A New Evaluation Method of Frailty to Estimate Muscle Mass by Using 3-Axis Accelerometer. Clin Nutr 2016. [DOI: 10.1016/s0261-5614(16)30772-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
60
|
Okawa R, Iijima O, Kishino M, Okawa H, Toyosawa S, Sugano-Tajima H, Shimada T, Okada T, Ozono K, Ooshima T, Nakano K. Gene therapy improves dental manifestations in hypophosphatasia model mice. J Periodontal Res 2016; 52:471-478. [PMID: 27561677 DOI: 10.1111/jre.12412] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/07/2016] [Indexed: 01/31/2023]
Abstract
BACKGROUND AND OBJECTIVE Hypophosphatasia is a rare inherited skeletal disorder characterized by defective bone mineralization and deficiency of tissue non-specific alkaline phosphatase (TNSALP) activity. The disease is caused by mutations in the liver/bone/kidney alkaline phosphatase gene (ALPL) encoding TNSALP. Early exfoliation of primary teeth owing to disturbed cementum formation, periodontal ligament weakness and alveolar bone resorption are major complications encountered in oral findings, and discovery of early loss of primary teeth in a dental examination often leads to early diagnosis of hypophosphatasia. Although there are no known fundamental treatments or effective dental approaches to prevent early exfoliation of primary teeth in affected patients, several possible treatments have recently been described, including gene therapy. Gene therapy has also been applied to TNSALP knockout mice (Alpl-/- ), which phenocopy the infantile form of hypophosphatasia, and improved their systemic condition. In the present study, we investigated whether gene therapy improved the dental condition of Alpl-/- mice. MATERIAL AND METHODS Following sublethal irradiation (4 Gy) at the age of 2 d, Alpl-/- mice underwent gene therapy using bone marrow cells transduced with a lentiviral vector expressing a bone-targeted form of TNSALP injected into the jugular vein (n = 3). Wild-type (Alpl+/+ ), heterozygous mice (Alpl+/- ) and Alpl-/- mice were analyzed at 9 d of age (n = 3 of each), while Alpl+/+ mice and treated or untreated Alpl-/- mice were analyzed at 1 mo of age (n = 3 of each), and Alpl+/- mice and Alpl-/- mice with gene therapy were analyzed at 3 mo of age (n = 3 of each). A single mandibular hemi-section obtained at 1 mo of age was analyzed using a small animal computed tomography machine to assess alveolar bone formation. Other mandibular hemi-sections obtained at 9 d, 1 mo and 3 mo of age were subjected to hematoxylin and eosin staining and immunohistochemical analysis of osteopontin, a marker of cementum. RESULTS Immunohistochemical analysis of osteopontin, a marker of acellular cementum, revealed that Alpl-/- mice displayed impaired formation of cementum and alveolar bone, similar to the human dental phenotype. Cementum formation was clearly present in Alpl-/- mice that underwent gene therapy, but did not recover to the same level as that in wild-type (Alpl+/+ ) mice. Micro-computed tomography examination showed that gene therapy improved alveolar bone mineral density in Alpl-/- mice to a similar level to that in Alpl+/+ mice. CONCLUSIONS Our results suggest that gene therapy can improve the general condition of Alpl-/- mice, and induce significant alveolar bone formation and moderate improvement of cementum formation, which may contribute to inhibition of early spontaneous tooth exfoliation.
Collapse
|
61
|
Naka S, Nomura R, Takashima Y, Okawa R, Ooshima T, Nakano K. A specific Streptococcus mutans strain aggravates non-alcoholic fatty liver disease. Oral Dis 2016; 20:700-6. [PMID: 25360469 DOI: 10.1111/odi.12191] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
OBJECTIVE Streptococcus mutans, a major dental caries pathogen, has shown to be associated with the aggravation of cerebral hemorrhage and inflammatory bowel diseases. In this study, we evaluated the effects ofS. mutans on the development of non-alcoholic steatohepatitis (NASH) in a mouse model. MATERIALS AND METHODS Streptococcus mutans oral strain MT8148 (serotype c) and a blood isolate TW871 (k) were used. C57BL/6J mice (6 weeks old)were fed a high-fat diet for 4 weeks; the test strains or phosphate-buffered saline was then intravenously administered. Mice were euthanized after 8 or 12 weeks. Whole body, extirpated liver, and visceral fat weights were determined, and histopathological evaluations of the liver specimens were performed. RESULTS Mice infected with TW871 showed significantly greater body and liver weights than those administered MT8148 or phosphate-buffered saline. Histopathological analyses revealed prominent infiltration of inflammatory cells and adipocellular deposition in livers extirpated 8 weeks after an infection with TW871; fibrosis was also observed in livers extirpated after 12 weeks. CONCLUSION These results suggest that a specific strain of S. mutans could induce NASH.
Collapse
|
62
|
Nagaya M, Matsunari H, Kanai T, Maehara M, Nakano K, Umeki I, Katsumata Y, Kasai Y, Sakai R, Kobayashi M, Honda M, Abe N, Watanabe M, Umeyama K, Nagashima H. An Effective New Cryopreservation Procedure for Pancreatic Islets Using Hollow Fiber Vitrification. Horm Metab Res 2016; 48:540-9. [PMID: 27341475 DOI: 10.1055/s-0042-102628] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
The present study aimed at establishing a new cryopreservation method for mouse pancreatic islets by vitrification using hollow fibers as a container. A unique feature of the hollow fiber vitrification (HFV) method is that this method achieves stable vitrification using a minimum volume of cryoprotectant (CPA) solution, thereby ensuring high viability of the islets. The cytotoxicity, optimum composition, and concentration of the CPAs for vitrifying islets were examined. The viability, functional-integrity of vitrified islets were evaluated in comparison with those vitrified by conventional methods. Insulin secretion was measured in vitro by a static incubation assay and the metabolic functions was tested after transplantation into Streptozotocin-induced diabetic mice. The combination of 15% dimethyl sulfoxide+15% ethylene glycol resulted in the best CPA solution for the HFV of islets. HFV showed the highest viability in comparison to 2 vitrification methods, open pulled straws and vitrification with EDT324 solution. The vitrified islets stably expressed β-cells markers NeuroD, Pancreatic and duodenal homeobox-1, and MafA. Transplantation of the vitrified islets achieved euglycemia of the host diabetic mice and response to an intraperitoneal glucose tolerance test to a similar extent as non-vitrified transplanted islets. The HFV method allows for efficient long-term cryopreservation of islets.
Collapse
|
63
|
Itoh K, Mitsuoka T, Maejima K, Hiraga C, Nakano K. Comparison of faecal flora of cats based on different housing conditions with special reference to Bifidobacterium. Lab Anim 2016. [DOI: 10.1258/002367784780958303] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Faecal flora of cats was compared in different colonies. In conventional cats there were no significant qualitative differences in composition of faecal flora in 3 colonies but there was variation in numbers of enterobacteriaceae, streptococci, bifidobacteria and clostridia, Bacteroidaceae and eubacteria were the most predominant nora followed by clostridia, streptococci and lactobacilli. In SPF cats produced by hysterectomy, the numbers of clostridia and enterobacteriaceae and the frequency of occurrence of staphylococci were higher than in conventional cats, and the numbers of bacterioidaceae and lactobacilli were much lower. 44 strains of bifidobacteria isolated from the faeces of cats were identified as Bifidobacterium adolescentis biovar b and d.
Collapse
|
64
|
Sakata K, Nakayamada S, Miyazaki Y, Kubo S, Nakano K, Tanaka Y. OP0162 Toll-like Receptor 7-, but Not Toll-like Receptor 9-, Mediated Interferon-α Production from Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
65
|
Nakayamada S, Kubo S, Yoshikawa M, Miyazaki Y, Yunoue N, Iwata S, Nakano K, Saito K, Tanaka Y. FRI0095 Diversity of The Peripheral Immunological Phenotype after Biologic DMARD Therapy in Patients with Rheumatoid Arthritis. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
66
|
Miyagawa I, Nakayamada S, Nakano K, Yamagata K, Sakata K, Yamaoka K, Tanaka Y. THU0027 Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2843] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
67
|
Hirata S, Tang S, Hwang C, Miyagawa I, Kubo S, Nakano K, Nakayamada S, Saito K, Defranoux N, Tanaka Y. FRI0096 Predictive Value of The Multi-Biomarker Disease Activity (MBDA) Score for Flare and Sustained Remission in The Honor Study. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.3357] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
68
|
Kubo S, Nakayamada S, Nakano K, Tanaka Y. THU0203 Baricitinib Targets The Type I IFN/STAT-Medicated Activities of Human T Cells and Dendritic Cells. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2222] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
69
|
Saito K, Nakano K, Nakayamada S, Kubo S, Miyagawa I, Hirata S, Tanaka Y. FRI0223 The Best Selection of Second Biologics for Patients with Rheumatoid Arthritis in Daily Clinical Practice. Ann Rheum Dis 2016. [DOI: 10.1136/annrheumdis-2016-eular.2844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
70
|
Adare A, Aidala C, Ajitanand NN, Akiba Y, Al-Bataineh H, Alexander J, Alfred M, Angerami A, Aoki K, Apadula N, Aramaki Y, Asano H, Atomssa ET, Averbeck R, Awes TC, Azmoun B, Babintsev V, Bai M, Baksay G, Baksay L, Bandara NS, Bannier B, Barish KN, Bassalleck B, Basye AT, Bathe S, Baublis V, Baumann C, Bazilevsky A, Beaumier M, Beckman S, Belikov S, Belmont R, Bennett R, Berdnikov A, Berdnikov Y, Bhom JH, Blau DS, Bok JS, Boyle K, Brooks ML, Bryslawskyj J, Buesching H, Bumazhnov V, Bunce G, Butsyk S, Campbell S, Caringi A, Chen CH, Chi CY, Chiu M, Choi IJ, Choi JB, Choudhury RK, Christiansen P, Chujo T, Chung P, Chvala O, Cianciolo V, Citron Z, Cole BA, Conesa Del Valle Z, Connors M, Csanád M, Csörgő T, Dahms T, Dairaku S, Danchev I, Danley TW, Das K, Datta A, Daugherity MS, David G, Dayananda MK, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond EJ, Dharmawardane KV, Dietzsch O, Dion A, Diss PB, Do JH, Donadelli M, D'Orazio L, Drapier O, Drees A, Drees KA, Durham JM, Durum A, Dutta D, Edwards S, Efremenko YV, Ellinghaus F, Engelmore T, Enokizono A, En'yo H, Esumi S, Fadem B, Feege N, Fields DE, Finger M, Finger M, Fleuret F, Fokin SL, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fujiwara K, Fukao Y, Fusayasu T, Gal C, Gallus P, Garg P, Garishvili I, Ge H, Giordano F, Glenn A, Gong H, Gonin M, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grim G, Grosse Perdekamp M, Gunji T, Gustafsson HÅ, Hachiya T, Haggerty JS, Hahn KI, Hamagaki H, Hamblen J, Hamilton HF, Han R, Han SY, Hanks J, Hasegawa S, Haseler TOS, Hashimoto K, Haslum E, Hayano R, He X, Heffner M, Hemmick TK, Hester T, Hill JC, Hohlmann M, Hollis RS, Holzmann W, Homma K, Hong B, Horaguchi T, Hornback D, Hoshino T, Hotvedt N, Huang J, Huang S, Ichihara T, Ichimiya R, Ikeda Y, Imai K, Inaba M, Iordanova A, Isenhower D, Ishihara M, Issah M, Ivanishchev D, Iwanaga Y, Jacak BV, Jezghani M, Jia J, Jiang X, Jin J, Johnson BM, Jones T, Joo KS, Jouan D, Jumper DS, Kajihara F, Kamin J, Kanda S, Kang JH, Kapustinsky J, Karatsu K, Kasai M, Kawall D, Kawashima M, Kazantsev AV, Kempel T, Key JA, Khachatryan V, Khanzadeev A, Kijima KM, Kikuchi J, Kim A, Kim BI, Kim C, Kim DJ, Kim EJ, Kim GW, Kim M, Kim YJ, Kimelman B, Kinney E, Kiss Á, Kistenev E, Kitamura R, Klatsky J, Kleinjan D, Kline P, Koblesky T, Kochenda L, Komkov B, Konno M, Koster J, Kotov D, Král A, Kravitz A, Kunde GJ, Kurita K, Kurosawa M, Kwon Y, Kyle GS, Lacey R, Lai YS, Lajoie JG, Lebedev A, Lee DM, Lee J, Lee KB, Lee KS, Lee S, Lee SH, Leitch MJ, Leite MAL, Li X, Lichtenwalner P, Liebing P, Lim SH, Linden Levy LA, Liška T, Liu H, Liu MX, Love B, Lynch D, Maguire CF, Makdisi YI, Makek M, Malik MD, Manion A, Manko VI, Mannel E, Mao Y, Masui H, Matathias F, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Means N, Meles A, Mendoza M, Meredith B, Miake Y, Mibe T, Mignerey AC, Miki K, Milov A, Mishra DK, Mitchell JT, Miyasaka S, Mizuno S, Mohanty AK, Montuenga P, Moon HJ, Moon T, Morino Y, Morreale A, Morrison DP, Moukhanova TV, Murakami T, Murata J, Mwai A, Nagamiya S, Nagashima K, Nagle JL, Naglis M, Nagy MI, Nakagawa I, Nakagomi H, Nakamiya Y, Nakamura KR, Nakamura T, Nakano K, Nam S, Nattrass C, Netrakanti PK, Newby J, Nguyen M, Nihashi M, Niida T, Nishimura S, Nouicer R, Novák T, Novitzky N, Nyanin AS, Oakley C, O'Brien E, Oda SX, Ogilvie CA, Oka M, Okada K, Onuki Y, Orjuela Koop JD, Osborn JD, Oskarsson A, Ouchida M, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park IH, Park JS, Park S, Park SK, Park WJ, Pate SF, Patel M, Pei H, Peng JC, Pereira H, Perepelitsa DV, Perera GDN, Peressounko DY, Perry J, Petti R, Pinkenburg C, Pinson R, Pisani RP, Proissl M, Purschke ML, Qu H, Rak J, Ramson BJ, Ravinovich I, Read KF, Rembeczki S, Reygers K, Reynolds D, Riabov V, Riabov Y, Richardson E, Rinn T, Roach D, Roche G, Rolnick SD, Rosati M, Rosen CA, Rosendahl SSE, Rowan Z, Rubin JG, Ružička P, Sahlmueller B, Saito N, Sakaguchi T, Sakashita K, Sako H, Samsonov V, Sano S, Sarsour M, Sato S, Sato T, Sawada S, Schaefer B, Schmoll BK, Sedgwick K, Seele J, Seidl R, Sen A, Seto R, Sett P, Sexton A, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shoji K, Shukla P, Sickles A, Silva CL, Silvermyr D, Silvestre C, Sim KS, Singh BK, Singh CP, Singh V, Slunečka M, Snowball M, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Stankus PW, Stenlund E, Stepanov M, Stoll SP, Sugitate T, Sukhanov A, Sumita T, Sun J, Sziklai J, Takagui EM, Taketani A, Tanabe R, Tanaka Y, Taneja S, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Themann H, Thomas D, Thomas TL, Tieulent R, Timilsina A, Todoroki T, Togawa M, Toia A, Tomášek L, Tomášek M, Torii H, Towell CL, Towell R, Towell RS, Tserruya I, Tsuchimoto Y, Vale C, Valle H, van Hecke HW, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Virius M, Vrba V, Vznuzdaev E, Wang XR, Watanabe D, Watanabe K, Watanabe Y, Watanabe YS, Wei F, Wei R, Wessels J, White AS, White SN, Winter D, Woody CL, Wright RM, Wysocki M, Xia B, Xue L, Yalcin S, Yamaguchi YL, Yamaura K, Yang R, Yanovich A, Ying J, Yokkaichi S, Yoo JH, Yoon I, You Z, Young GR, Younus I, Yu H, Yushmanov IE, Zajc WA, Zelenski A, Zhou S, Zou L. Centrality-Dependent Modification of Jet-Production Rates in Deuteron-Gold Collisions at √[s(NN)]=200 GeV. PHYSICAL REVIEW LETTERS 2016; 116:122301. [PMID: 27058071 DOI: 10.1103/physrevlett.116.122301] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/05/2015] [Indexed: 06/05/2023]
Abstract
Jet production rates are measured in p+p and d+Au collisions at sqrt[s_{NN}]=200 GeV recorded in 2008 with the PHENIX detector at the Relativistic Heavy Ion Collider. Jets are reconstructed using the R=0.3 anti-k_{t} algorithm from energy deposits in the electromagnetic calorimeter and charged tracks in multiwire proportional chambers, and the jet transverse momentum (p_{T}) spectra are corrected for the detector response. Spectra are reported for jets with 12<p_{T}<50 GeV/c, within a pseudorapidity acceptance of |η|<0.3. The nuclear-modification factor (R_{dAu}) values for 0%-100% d+Au events are found to be consistent with unity, constraining the role of initial state effects on jet production. However, the centrality-selected R_{dAu} values and central-to-peripheral ratios (R_{CP}) show large, p_{T}-dependent deviations from unity, challenging the conventional models that relate hard-process rates and soft-particle production in collisions involving nuclei.
Collapse
|
71
|
Petrova AV, Ishimatsu R, Nakano K, Imato T, Vishnikin AB, Moskvin LN, Bulatov AV. Flow-Injection Spectrophotometric Determination of Cysteine in Biologically Active Dietary Supplements. JOURNAL OF ANALYTICAL CHEMISTRY 2016. [DOI: 10.1134/s1061934816020118] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
72
|
Kobayashi T, Nakano K, Tomomatsu J, Nara E, Ito Y, Kobayashi K, Fukada I, Araki K, Shimomura A, Shimoi T, Kodaira M, Yunokawa M, Yonemori K, Shimizu C, Nakamura K, Kotani N, Inatani M, Tamura K, Takahashi S. Abstract P3-14-10: Phase Ia/Ib study of taselisib (GDC-0032), a potent and selective phosphoinositide 3-kinase inhibitor, in Japanese patients with advanced solid tumors or hormone receptor-positive locally advanced or metastatic breast cancer (JO29196 study). Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p3-14-10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background:
Taselisib (GDC-0032) is an orally bioavailable, potent and selective phosphoinositide 3-kinase (PI3K) inhibitor. Preclinical data showed that taselisib had increased antitumor activity against PIK3CA (gene encoding the PI3Kα isoform) mutant tumors. This study aimed to investigate the safety, tolerability and pharmacokinetics (PK) of taselisib as monotherapy and in combination with fulvestrant in Japanese patients (pts).
Materials and methods:
A 3+3 design was used. In Phase Ia, pts with advanced solid tumors received taselisib tablet monotherapy (2, 4 or 6 mg once daily [QD]), and safety and PK were evaluated. In Phase Ib, pts with hormone receptor-positive locally advanced or metastatic breast cancer received taselisib (2 or 4 mg QD) in combination with fulvestrant (500 mg at a time), and safety and PK were evaluated. Maximal administered doses of 6 mg QD as a single agent and 4 mg QD in combination with fulvestrant were based upon prior clinical trial experience with taselisib (Juric D. et al. AACR 2013, Abstract LB-64; Juric D. et al. SABCS 2013, Abstract PD1-3).
Results:
As of 15 Mar 2015, 9 pts (PIK3CA mutant: 2 pts) were enrolled in Phase Ia and 3 pts in Phase Ib. Phase Ia dose-escalation study has been completed and Phase Ib is ongoing.
In Phase Ia, no dose-limiting toxicity (DLT) was observed at any dose level tested (maximum administered dose of 6 mg QD). Common (≥3 pts) adverse reactions (ARs) were stomatitis (4 pts), rash (3 pts) and diarrhea (3 pts); the only Grade ≥3 AR was neutropenia (1 pt). Partial response was observed in 1 pt who received taselisib 4 mg and had a PIK3CA mutant breast tumor. Stable disease was observed in 4 pts. Cmax and AUC indicated a dose-proportional PK profile of taselisib within the dose range tested. Moreover, taselisib PK in Japanese pts was consistent with the PK reported from North American and European pts (Juric D. et al. AACR 2013, Abstract LB-64).
In Phase Ib, 3 pts received taselisib 2 mg in combination with fulvestrant and no DLT was observed. Preliminary ARs were similar to those with monotherapy and no Grade ≥3 AR was reported. Confirmation of tolerability of taselisib 4 mg in combination with fulvestrant is under evaluation.
Conclusion:
Taselisib monotherapy was well tolerated in Japanese pts up to a dose of 6 mg, which is the recommended dose in non-Japanese pts. Promising preliminary activity of monotherapy was observed in advanced solid tumors, especially in a pt with PIK3CA mutant tumor. The combination of taselisib 2 mg with fulvestrant is well tolerated. Investigation of tolerability of taselisib 4 mg in combination with fulvestrant is ongoing. Final results of this study will be presented here at the Symposium this year.
Citation Format: Kobayashi T, Nakano K, Tomomatsu J, Nara E, Ito Y, Kobayashi K, Fukada I, Araki K, Shimomura A, Shimoi T, Kodaira M, Yunokawa M, Yonemori K, Shimizu C, Nakamura K, Kotani N, Inatani M, Tamura K, Takahashi S. Phase Ia/Ib study of taselisib (GDC-0032), a potent and selective phosphoinositide 3-kinase inhibitor, in Japanese patients with advanced solid tumors or hormone receptor-positive locally advanced or metastatic breast cancer (JO29196 study). [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P3-14-10.
Collapse
|
73
|
Adare A, Aidala C, Ajitanand N, Akiba Y, Akimoto R, Alexander J, Alfred M, Aoki K, Apadula N, Aramaki Y, Asano H, Atomssa E, Awes T, Azmoun B, Babintsev V, Bai M, Bai X, Bandara N, Bannier B, Barish K, Bathe S, Baublis V, Baumann C, Baumgart S, Bazilevsky A, Beaumier M, Beckman S, Belmont R, Berdnikov A, Berdnikov Y, Black D, Blau D, Bok J, Boyle K, Brooks M, Bryslawskyj J, Buesching H, Bumazhnov V, Butsyk S, Campbell S, Chen CH, Chi C, Chiu M, Choi I, Choi J, Choi S, Christiansen P, Chujo T, Cianciolo V, Citron Z, Cole B, Cronin N, Crossette N, Csanád M, Csörgő T, Danley T, Datta A, Daugherity M, David G, DeBlasio K, Dehmelt K, Denisov A, Deshpande A, Desmond E, Ding L, Dion A, Diss P, Do J, D’Orazio L, Drapier O, Drees A, Drees K, Durham J, Durum A, Engelmore T, Enokizono A, En’yo H, Esumi S, Eyser K, Fadem B, Feege N, Fields D, Finger M, Finger M, Fleuret F, Fokin S, Frantz J, Franz A, Frawley A, Fukao Y, Fusayasu T, Gainey K, Gal C, Gallus P, Garg P, Garishvili A, Garishvili I, Ge H, Giordano F, Glenn A, Gong X, Gonin M, Goto Y, Granier de Cassagnac R, Grau N, Greene S, Grosse Perdekamp M, Gu Y, Gunji T, Guragain H, Hachiya T, Haggerty J, Hahn K, Hamagaki H, Hamilton H, Han S, Hanks J, Hasegawa S, Haseler T, Hashimoto K, Hayano R, He X, Hemmick T, Hester T, Hill J, Hollis R, Homma K, Hong B, Hoshino T, Hotvedt N, Huang J, Huang S, Ichihara T, Ikeda Y, Imai K, Imazu Y, Inaba M, Iordanova A, Isenhower D, Isinhue A, Ivanishchev D, Jacak B, Jeon S, Jezghani M, Jia J, Jiang X, Johnson B, Joo E, Joo K, Jouan D, Jumper D, Kamin J, Kanda S, Kang B, Kang J, Kang J, Kapustinsky J, Kawall D, Kazantsev A, Key J, Khachatryan V, Khandai P, Khanzadeev A, Kihara K, Kijima K, Kim C, Kim D, Kim D, Kim EJ, Kim G, Kim HJ, Kim M, Kim YJ, Kim Y, Kimelman B, Kistenev E, Kitamura R, Klatsky J, Kleinjan D, Kline P, Koblesky T, Kofarago M, Komkov B, Koster J, Kotchetkov D, Kotov D, Krizek F, Kurita K, Kurosawa M, Kwon Y, Lacey R, Lai Y, Lajoie J, Lebedev A, Lee D, Lee G, Lee J, Lee K, Lee K, Lee S, Lee S, Leitch M, Leitgab M, Lewis B, Li X, Lim S, Liu M, Lynch D, Maguire C, Makdisi Y, Makek M, Manion A, Manko V, Mannel E, Maruyama T, McCumber M, McGaughey P, McGlinchey D, McKinney C, Meles A, Mendoza M, Meredith B, Miake Y, Mibe T, Mignerey A, Miller A, Milov A, Mishra D, Mitchell J, Miyasaka S, Mizuno S, Mohanty A, Mohapatra S, Montuenga P, Moon T, Morrison D, Moskowitz M, Moukhanova T, Murakami T, Murata J, Mwai A, Nagae T, Nagamiya S, Nagashima K, Nagle J, Nagy M, Nakagawa I, Nakagomi H, Nakamiya Y, Nakamura K, Nakamura T, Nakano K, Nattrass C, Netrakanti P, Nihashi M, Niida T, Nishimura S, Nouicer R, Novák T, Novitzky N, Nyanin A, O’Brien E, Ogilvie C, Oide H, Okada K, Orjuela Koop J, Osborn J, Oskarsson A, Ozaki H, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park I, Park J, Park S, Park S, Pate S, Patel L, Patel M, Peng JC, Perepelitsa D, Perera G, Peressounko D, Perry J, Petti R, Pinkenburg C, Pinson R, Pisani R, Purschke M, Qu H, Rak J, Ramson B, Ravinovich I, Read K, Reynolds D, Riabov V, Riabov Y, Richardson E, Rinn T, Riveli N, Roach D, Rolnick S, Rosati M, Rowan Z, Rubin J, Ryu M, Sahlmueller B, Saito N, Sakaguchi T, Sako H, Samsonov V, Sarsour M, Sato S, Sawada S, Schaefer B, Schmoll B, Sedgwick K, Seele J, Seidl R, Sekiguchi Y, Sen A, Seto R, Sett P, Sexton A, Sharma D, Shaver A, Shein I, Shibata TA, Shigaki K, Shimomura M, Shoji K, Shukla P, Sickles A, Silva C, Silvermyr D, Singh B, Singh C, Singh V, Skolnik M, Slunečka M, Snowball M, Solano S, Soltz R, Sondheim W, Sorensen S, Sourikova I, Stankus P, Steinberg P, Stenlund E, Stepanov M, Ster A, Stoll S, Stone M, Sugitate T, Sukhanov A, Sumita T, Sun J, Sziklai J, Takahara A, Taketani A, Tanaka Y, Tanida K, Tannenbaum M, Tarafdar S, Taranenko A, Tennant E, Tieulent R, Timilsina A, Todoroki T, Tomášek M, Torii H, Towell C, Towell M, Towell R, Towell R, Tserruya I, van Hecke H, Vargyas M, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Virius M, Vrba V, Vznuzdaev E, Wang X, Watanabe D, Watanabe K, Watanabe Y, Watanabe Y, Wei F, Whitaker S, White A, Wolin S, Woody C, Wysocki M, Xia B, Xue L, Yalcin S, Yamaguchi Y, Yanovich A, Yokkaichi S, Yoo J, Yoon I, You Z, Younus I, Yu H, Yushmanov I, Zajc W, Zelenski A, Zhou S, Zou L. Inclusive cross section and double-helicity asymmetry forπ0production at midrapidity inp+pcollisions ats=510 GeV. Int J Clin Exp Med 2016. [DOI: 10.1103/physrevd.93.011501] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
74
|
Nakano K, Yasuda K, Shibuya H, Moriyama T, Kahata K, Shimizu C. Transient human anti-mouse antibody generated with immune enhancement in a carbohydrate antigen 19-9 immunoassay after surgical resection of recurrent cancer. Ann Clin Biochem 2016; 53:511-5. [PMID: 26744502 DOI: 10.1177/0004563215626952] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/22/2015] [Indexed: 11/16/2022]
Abstract
UNLABELLED We report a case of transient human anti-mouse antibody from a 64-year-old man in a carbohydrate antigen 19-9 immunoassay using an AIA 1800 analyser that generated immune enhancement after surgical resection of recurrent cancer. METHODS The carbohydrate antigen 19-9 concentration was measured using an AIA 1800 analyser and a UniCel Dxl 800. Size-exclusion high-performance liquid chromatography was carried out on a Superose 12 column to estimate the carbohydrate antigen 19-9 elution profile using an AIA 1800 analyser. To determine whether IgM in the patient contributed to the carbohydrate antigen 19-9 immunoassay, immunoprecipitation was performed. Furthermore, mouse immunoglobulins were added to the patient's serum to verify that the patient's IgM reacted with it. RESULTS The carbohydrate antigen 19-9 concentration was >400 and 9.5 kU/L using an AIA 1800 analyser and using a UniCel Dxl 800, respectively. In the single carbohydrate antigen 19-9 peak, the molecular weight corresponded to IgM by size-exclusion high-performance liquid chromatography on a Superose 12 column. In the immunoprecipitation reaction and addition of mouse immunoglobulins, there was interference for anti-human IgM and mouse immunoglobulins whose recoveries were 3.2 and 14.2%, respectively. These results indicated that IgM in the patient's serum interfered with the carbohydrate antigen 19-9 immunoassay using an AIA 1800 analyser. CONCLUSION A novel transient human anti-mouse antibody generated with immune activation in a carbohydrate antigen 19-9 immunoassay using an AIA 1800 analyser was identified in a patient with rectal cancer after surgical resection. These findings demonstrate the importance of monitoring tumour markers in patients after treatment with mouse monoclonal antibody.
Collapse
|
75
|
Suzuki S, Yamashita S, Fukushima T, Nakano K, Midorikawa S, Ohtsuru A, Yasumura S, Hosoya M, Kamiya K, Shimura H, Suzuki S, Nakamura I, Abe M. The protocol and preliminary baseline survey results of the thyroid ultrasound examination in Fukushima [Rapid Communication]. Endocr J 2016; 63:315-21. [PMID: 26924746 DOI: 10.1507/endocrj.ej15-0726] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
UNLABELLED After the Fukushima nuclear power plant accident on March 11, 2011, the public of Japan became particularly concerned about the possibility of an increased risk of childhood thyroid cancer, similar to what was observed after the Chernobyl's accident. Due to serious public health perception, there was an urgency to evaluate the baseline levels of childhood thyroid status in Fukushima prefecture. Therefore we have commenced a thyroid ultrasound examination (TUE) survey of the approximately 360,000 pediatric inhabitants (0 to 18 years of age) who lived in Fukushima at the time of the accident in October 2011. The subjects were divided into three categories according to the standardized diagnostic criteria of ultrasound findings. Category A contained the subjects whose TUE findings were intact or benign. Category B were recommended a confirmatory TUE. Category C was recommended an immediate confirmatory TUE. RESULTS The survey of 40,302 subjects in the first year was completed in March, 2013. There were 40,097 (99.5%), 205 (0.50%) and 0 subjects in categories A, B and C, respectively. Of the 82 category B subjects who underwent fine needle aspiration cytology (FNAC), 12 were diagnosed with a malignant tumor or were suspected to have malignancy. The 12 subjects received thyroid surgery and 11 thyroid cancers and one benign nodule were confirmed histologically after surgery. This is the first large-scaled TUE survey to employ sophisticated ultrasound screening and aim to evaluate the baseline frequency of childhood thyroid nodules and cysts. The results will become the golden standard of future comparative TUE in Fukushima, Japan.
Collapse
|
76
|
Castelijns B, Ponten JEH, Van de Poll MCG, Nienhuijs SW, Smulders JF, Hu ZW, Wu JM, Wang ZG, Idani H, Asami S, Nakano K, Miyake S, Harano M, Miyoshi H, Araki H, Ogawa T, Takahashi K, Shiozaki S, Ninomiya M, Prasad A, Todkar J, Asti E, Lovece A, Sironi A, Bonavina L, Wright R, Wurst H, Zhang C, Li HL, Ke LM, Loi K, Hua R, Yao QY, Chen H, Okinyi W, Odende K, Ndungu B, Ndonga A, Kiragu P, Kelimu A, Alimujiang M, Tian W, Bing M. Hiatal Hernia. Hernia 2015; 19 Suppl 1:S13-7. [PMID: 26518789 DOI: 10.1007/bf03355320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
77
|
Nakano K, Idani H, Asami S, Ookawa H, Yoshimoto M, Ito A, Monden K, Kurose Y, Hioki M, Ishii T, Sadamori H, Oono S, Kin H, Takakura N. Topic: Abdominal Wall Hernia - Abdominal wall closure. Hernia 2015; 19 Suppl 1:S342. [PMID: 26518836 DOI: 10.1007/bf03355382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
78
|
Adare A, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Akimoto R, Al-Bataineh H, Alexander J, Alfred M, Al-Ta'ani H, Andrews KR, Angerami A, Aoki K, Apadula N, Aphecetche L, Appelt E, Aramaki Y, Armendariz R, Aronson SH, Asai J, Asano H, Aschenauer EC, Atomssa ET, Averbeck R, Awes TC, Azmoun B, Babintsev V, Bai M, Baksay G, Baksay L, Baldisseri A, Bandara NS, Bannier B, Barish KN, Barnes PD, Bassalleck B, Basye AT, Bathe S, Batsouli S, Baublis V, Baumann C, Bazilevsky A, Beaumier M, Beckman S, Belikov S, Belmont R, Ben-Benjamin J, Bennett R, Berdnikov A, Berdnikov Y, Bhom JH, Bickley AA, Blau DS, Boissevain JG, Bok JS, Borel H, Boyle K, Brooks ML, Broxmeyer D, Bryslawskyj J, Buesching H, Bumazhnov V, Bunce G, Butsyk S, Camacho CM, Campbell S, Caringi A, Castera P, Chang BS, Chang WC, Charvet JL, Chen CH, Chernichenko S, Chi CY, Chiba J, Chiu M, Choi IJ, Choi JB, Choudhury RK, Christiansen P, Chujo T, Chung P, Churyn A, Chvala O, Cianciolo V, Citron Z, Cleven CR, Cole BA, Comets MP, Conesa del Valle Z, Connors M, Constantin P, Csanád M, Csörgő T, Dahms T, Dairaku S, Danchev I, Danley D, Das K, Datta A, Daugherity MS, David G, Dayananda MK, Deaton MB, DeBlasio K, Dehmelt K, Delagrange H, Denisov A, d'Enterria D, Deshpande A, Desmond EJ, Dharmawardane KV, Dietzsch O, Dion A, Diss PB, Do JH, Donadelli M, D'Orazio L, Drapier O, Drees A, Drees KA, Dubey AK, Durham JM, Durum A, Dutta D, Dzhordzhadze V, Edwards S, Efremenko YV, Egdemir J, Ellinghaus F, Emam WS, Engelmore T, Enokizono A, En'yo H, Esumi S, Eyser KO, Fadem B, Feege N, Fields DE, Finger M, Finger M, Fleuret F, Fokin SL, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fujiwara K, Fukao Y, Fusayasu T, Gadrat S, Gal C, Gallus P, Garg P, Garishvili I, Ge H, Giordano F, Glenn A, Gong H, Gong X, Gonin M, Gosset J, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grim G, Grosse Perdekamp M, Gu Y, Gunji T, Guo L, Gustafsson HÅ, Hachiya T, Hadj Henni A, Haegemann C, Haggerty JS, Hahn KI, Hamagaki H, Hamblen J, Hamilton HF, Han R, Han SY, Hanks J, Harada H, Harper C, Hartouni EP, Haruna K, Hasegawa S, Haseler TOS, Hashimoto K, Haslum E, Hayano R, He X, Heffner M, Hemmick TK, Hester T, Hiejima H, Hill JC, Hobbs R, Hohlmann M, Hollis RS, Holzmann W, Homma K, Hong B, Horaguchi T, Hori Y, Hornback D, Hoshino T, Hotvedt N, Huang J, Huang S, Ichihara T, Ichimiya R, Iinuma H, Ikeda Y, Imai K, Imrek J, Inaba M, Inoue Y, Iordanova A, Isenhower D, Isenhower L, Ishihara M, Isobe T, Issah M, Isupov A, Ivanishchev D, Iwanaga Y, Jacak BV, Jezghani M, Jia J, Jiang X, Jin J, Jinnouchi O, John D, Johnson BM, Jones T, Joo KS, Jouan D, Jumper DS, Kajihara F, Kametani S, Kamihara N, Kamin J, Kanda S, Kaneta M, Kaneti S, Kang BH, Kang JH, Kang JS, Kanou H, Kapustinsky J, Karatsu K, Kasai M, Kawall D, Kawashima M, Kazantsev AV, Kempel T, Key JA, Khachatryan V, Khanzadeev A, Kijima KM, Kikuchi J, Kim A, Kim BI, Kim C, Kim DH, Kim DJ, Kim E, Kim EJ, Kim GW, Kim M, Kim SH, Kim YJ, Kim YK, Kimelman B, Kinney E, Kiriluk K, Kiss Á, Kistenev E, Kitamura R, Kiyomichi A, Klatsky J, Klay J, Klein-Boesing C, Kleinjan D, Kline P, Koblesky T, Kochenda L, Kochetkov V, Komkov B, Konno M, Koster J, Kotchetkov D, Kotov D, Kozlov A, Král A, Kravitz A, Kubart J, Kunde GJ, Kurihara N, Kurita K, Kurosawa M, Kweon MJ, Kwon Y, Kyle GS, Lacey R, Lai YS, Lajoie JG, Layton D, Lebedev A, Lee DM, Lee J, Lee KB, Lee KS, Lee MK, Lee S, Lee SH, Lee SR, Lee T, Leitch MJ, Leite MAL, Lenzi B, Li X, Lichtenwalner P, Liebing P, Lim SH, Linden Levy LA, Liška T, Litvinenko A, Liu H, Liu MX, Love B, Lynch D, Maguire CF, Makdisi YI, Makek M, Malakhov A, Malik MD, Manion A, Manko VI, Mannel E, Mao Y, Mašek L, Masui H, Matathias F, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Means N, Meles A, Mendoza M, Meredith B, Miake Y, Mibe T, Mignerey AC, Mikeš P, Miki K, Miller TE, Milov A, Mioduszewski S, Mishra DK, Mishra M, Mitchell JT, Mitrovski M, Miyachi Y, Miyasaka S, Mizuno S, Mohanty AK, Montuenga P, Moon HJ, Moon T, Morino Y, Morreale A, Morrison DP, Motschwiller S, Moukhanova TV, Mukhopadhyay D, Murakami T, Murata J, Mwai A, Nagamiya S, Nagashima K, Nagata Y, Nagle JL, Naglis M, Nagy MI, Nakagawa I, Nakagomi H, Nakamiya Y, Nakamura KR, Nakamura T, Nakano K, Nam S, Nattrass C, Netrakanti PK, Newby J, Nguyen M, Nihashi M, Niida T, Nishimura S, Norman BE, Nouicer R, Novak T, Novitzky N, Nyanin AS, Oakley C, O'Brien E, Oda SX, Ogilvie CA, Ohnishi H, Oka M, Okada K, Omiwade OO, Onuki Y, Orjuela Koop JD, Osborn JD, Oskarsson A, Ouchida M, Ozawa K, Pak R, Pal D, Palounek APT, Pantuev V, Papavassiliou V, Park BH, Park IH, Park J, Park JS, Park S, Park SK, Park WJ, Pate SF, Patel L, Patel M, Pei H, Peng JC, Pereira H, Perepelitsa DV, Perera GDN, Peresedov V, Peressounko DY, Perry J, Petti R, Pinkenburg C, Pinson R, Pisani RP, Proissl M, Purschke ML, Purwar AK, Qu H, Rak J, Rakotozafindrabe A, Ramson BJ, Ravinovich I, Read KF, Rembeczki S, Reuter M, Reygers K, Reynolds D, Riabov V, Riabov Y, Richardson E, Rinn T, Roach D, Roche G, Rolnick SD, Romana A, Rosati M, Rosen CA, Rosendahl SSE, Rosnet P, Rowan Z, Rubin JG, Rukoyatkin P, Ružička P, Rykov VL, Sahlmueller B, Saito N, Sakaguchi T, Sakai S, Sakashita K, Sakata H, Sako H, Samsonov V, Sano S, Sarsour M, Sato S, Sato T, Savastio M, Sawada S, Schaefer B, Schmoll BK, Sedgwick K, Seele J, Seidl R, Semenov AY, Semenov V, Sen A, Seto R, Sett P, Sexton A, Sharma D, Shein I, Shevel A, Shibata TA, Shigaki K, Shim HH, Shimomura M, Shoji K, Shukla P, Sickles A, Silva CL, Silvermyr D, Silvestre C, Sim KS, Singh BK, Singh CP, Singh V, Skutnik S, Slunečka M, Snowball M, Sodre T, Soldatov A, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Staley F, Stankus PW, Stenlund E, Stepanov M, Ster A, Stoll SP, Sugitate T, Suire C, Sukhanov A, Sumita T, Sun J, Sziklai J, Tabaru T, Takagi S, Takagui EM, Takahara A, Taketani A, Tanabe R, Tanaka Y, Taneja S, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Tarján P, Tennant E, Themann H, Thomas D, Thomas TL, Tieulent R, Timilsina A, Todoroki T, Togawa M, Toia A, Tojo J, Tomášek L, Tomášek M, Tomita Y, Torii H, Towell CL, Towell R, Towell RS, Tram VN, Tserruya I, Tsuchimoto Y, Utsunomiya K, Vale C, Valle H, van Hecke HW, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Vinogradov AA, Virius M, Vossen A, Vrba V, Vznuzdaev E, Wagner M, Walker D, Wang XR, Watanabe D, Watanabe K, Watanabe Y, Watanabe YS, Wei F, Wei R, Wessels J, White AS, White SN, Winter D, Woody CL, Wright RM, Wysocki M, Xia B, Xie W, Xue L, Yalcin S, Yamaguchi YL, Yamaura K, Yang R, Yanovich A, Yasin Z, Ying J, Yokkaichi S, Yoo JH, Yoo JS, Yoon I, You Z, Young GR, Younus I, Yu H, Yushmanov IE, Zajc WA, Zaudtke O, Zelenski A, Zhang C, Zhou S, Zimamyi J, Zolin L, Zou L. Measurements of Elliptic and Triangular Flow in High-Multiplicity 3He+Au Collisions at √(s(NN))=200 GeV. PHYSICAL REVIEW LETTERS 2015; 115:142301. [PMID: 26551807 DOI: 10.1103/physrevlett.115.142301] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/22/2015] [Indexed: 06/05/2023]
Abstract
We present the first measurement of elliptic (v(2)) and triangular (v(3)) flow in high-multiplicity (3)He+Au collisions at √(s(NN))=200 GeV. Two-particle correlations, where the particles have a large separation in pseudorapidity, are compared in (3)He+Au and in p+p collisions and indicate that collective effects dominate the second and third Fourier components for the correlations observed in the (3)He+Au system. The collective behavior is quantified in terms of elliptic v(2) and triangular v(3) anisotropy coefficients measured with respect to their corresponding event planes. The v(2) values are comparable to those previously measured in d+Au collisions at the same nucleon-nucleon center-of-mass energy. Comparisons with various theoretical predictions are made, including to models where the hot spots created by the impact of the three (3)He nucleons on the Au nucleus expand hydrodynamically to generate the triangular flow. The agreement of these models with data may indicate the formation of low-viscosity quark-gluon plasma even in these small collision systems.
Collapse
|
79
|
Kuriyama N, Watanabe I, Miyatani F, Matsui D, Ozaki E, Nomura R, Nakano K, Watanabe Y. The Correlation between Microbleeds and Cnm-positive Streptococcus Mutans: A Pilot Survey Study Based on Magnetic Resonance Imaging. Int J Epidemiol 2015. [DOI: 10.1093/ije/dyv096.134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
80
|
Takashima Y, Fujita K, Ardin A, Nagayama K, Nomura R, Nakano K, Matsumoto-Nakano M. Characterization of the dextran-binding domain in the glucan-binding protein C of Streptococcus mutans. J Appl Microbiol 2015; 119:1148-57. [DOI: 10.1111/jam.12895] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2015] [Revised: 05/22/2015] [Accepted: 06/09/2015] [Indexed: 11/30/2022]
|
81
|
Kawai A, Araki N, Ando Y, Nakano K, Machida M, Yoshida P. 3438 Post marketing surveillance (PMS) in Japan for soft tissue sarcoma (STS) patients treated with pazopanib. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31911-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
82
|
Miyatani F, Kuriyama N, Watanabe I, Nomura R, Nakano K, Matsui D, Ozaki E, Koyama T, Nishigaki M, Yamamoto T, Mizuno T, Tamura A, Akazawa K, Takada A, Takeda K, Yamada K, Nakagawa M, Ihara M, Kanamura N, Friedland RP, Watanabe Y. Relationship between Cnm-positive Streptococcus mutans and cerebral microbleeds in humans. Oral Dis 2015. [PMID: 26205098 DOI: 10.1111/odi.12360] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE Cerebral hemorrhage has been shown to occur in animals experimentally infected with Streptococcus mutans carrying the collagen-binding Cnm gene. However, the relationship between cerebral microbleeds and oral hygiene, with a focus on Cnm gene-positive S. mutans infection, remains unclear. MATERIAL AND METHODS One hundred and thirty-nine subjects participated. The presence or absence of Cnm-positive S. mutans and its collagen-binding activity were investigated using saliva samples, and relationship with cerebral microbleeds detected on MRI investigated, including clinical information and oral parameters. RESULTS Fifty-one subjects were identified as Cnm-positive S. mutans carriers (36.7%), with cerebral microbleeds being detected in 43 (30.9%). A significantly larger number of subjects carried Cnm-positive S. mutans in the cerebral microbleeds (+) group. S. mutans with Cnm collagen-binding ability was detected in 39 (28.1%) of all subjects, and the adjusted odds ratio for cerebral microbleeds in the Cnm-positive group was 14.4. Regarding the presence of cerebral microbleeds, no significant differences were noted in the number of remaining teeth, dental caries, or in classic arteriosclerosis risk factors. CONCLUSIONS The occurrence of cerebral microbleeds was higher in subjects carrying Cnm-positive S. mutans, indicating that the presence of Cnm-positive S. mutans increases cerebral microbleeds, and is an independent risk for the development of cerebrovascular disorders.
Collapse
|
83
|
Moriyama T, Tamura S, Nakano K, Otsuka K, Shigemura M, Honma N. Laboratory and clinical features of abnormal macroenzymes found in human sera. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS 2015; 1854:658-67. [DOI: 10.1016/j.bbapap.2014.10.015] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2014] [Revised: 09/24/2014] [Accepted: 10/20/2014] [Indexed: 01/01/2023]
|
84
|
Kubo S, Nakayamada S, Nakano K, Hirata S, Fukuyo S, Miyagawa I, Hanami K, Saito K, Tanaka Y. SAT0207 Comparison of Efficacies of Abatacept and Tocilizumab in Patients with Rheumatoid Arthritis by a Propensity-Score Matching. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2248] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
85
|
Saito K, Nakano K, Nakayamada S, Hirata S, Kubo S, Fukuyo S, Miyagawa I, Sawamukai N, Hanami K, Tanaka Y. FRI0170 The Comparative Effectiveness of Five Biologics as Second-Line Use for Patients with Rheumatoid Arthritis in Daily Clinical Practice. Ann Rheum Dis 2015. [DOI: 10.1136/annrheumdis-2015-eular.2020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
86
|
Adare A, Aidala C, Ajitanand NN, Akiba Y, Akimoto R, Al-Bataineh H, Al-Ta'ani H, Alexander J, Andrews KR, Angerami A, Aoki K, Apadula N, Appelt E, Aramaki Y, Armendariz R, Aschenauer EC, Atomssa ET, Averbeck R, Awes TC, Azmoun B, Babintsev V, Bai M, Baksay G, Baksay L, Bannier B, Barish KN, Bassalleck B, Basye AT, Bathe S, Baublis V, Baumann C, Bazilevsky A, Belikov S, Belmont R, Ben-Benjamin J, Bennett R, Bhom JH, Blau DS, Bok JS, Boyle K, Brooks ML, Broxmeyer D, Buesching H, Bumazhnov V, Bunce G, Butsyk S, Campbell S, Caringi A, Castera P, Chen CH, Chi CY, Chiu M, Choi IJ, Choi JB, Choudhury RK, Christiansen P, Chujo T, Chung P, Chvala O, Cianciolo V, Citron Z, Cole BA, Conesa Del Valle Z, Connors M, Csanád M, Csörgő T, Dahms T, Dairaku S, Danchev I, Das K, Datta A, David G, Dayananda MK, Denisov A, Deshpande A, Desmond EJ, Dharmawardane KV, Dietzsch O, Dion A, Donadelli M, Drapier O, Drees A, Drees KA, Durham JM, Durum A, Dutta D, D'Orazio L, Edwards S, Efremenko YV, Ellinghaus F, Engelmore T, Enokizono A, En'yo H, Esumi S, Fadem B, Fields DE, Finger M, Finger M, Fleuret F, Fokin SL, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fujiwara K, Fukao Y, Fusayasu T, Gal C, Garishvili I, Glenn A, Gong H, Gong X, Gonin M, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grim G, Grosse Perdekamp M, Gunji T, Guo L, Gustafsson HÅ, Haggerty JS, Hahn KI, Hamagaki H, Hamblen J, Han R, Hanks J, Harper C, Hashimoto K, Haslum E, Hayano R, He X, Heffner M, Hemmick TK, Hester T, Hill JC, Hohlmann M, Hollis RS, Holzmann W, Homma K, Hong B, Horaguchi T, Hori Y, Hornback D, Huang S, Ichihara T, Ichimiya R, Iinuma H, Ikeda Y, Imai K, Inaba M, Iordanova A, Isenhower D, Ishihara M, Issah M, Ivanischev D, Iwanaga Y, Jacak BV, Jia J, Jiang X, Jin J, John D, Johnson BM, Jones T, Joo KS, Jouan D, Jumper DS, Kajihara F, Kamin J, Kaneti S, Kang BH, Kang JH, Kang JS, Kapustinsky J, Karatsu K, Kasai M, Kawall D, Kawashima M, Kazantsev AV, Kempel T, Khanzadeev A, Kijima KM, Kikuchi J, Kim A, Kim BI, Kim DJ, Kim EJ, Kim YJ, Kim YK, Kinney E, Kiss Á, Kistenev E, Kleinjan D, Kline P, Kochenda L, Komkov B, Konno M, Koster J, Kotov D, Král A, Kravitz A, Kunde GJ, Kurita K, Kurosawa M, Kwon Y, Kyle GS, Lacey R, Lai YS, Lajoie JG, Lebedev A, Lee DM, Lee J, Lee KB, Lee KS, Lee SH, Lee SR, Leitch MJ, Leite MAL, Li X, Lichtenwalner P, Liebing P, Lim SH, Linden Levy LA, Liška T, Liu H, Liu MX, Love B, Lynch D, Maguire CF, Makdisi YI, Malik MD, Manion A, Manko VI, Mannel E, Mao Y, Masui H, Matathias F, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Means N, Mendoza M, Meredith B, Miake Y, Mibe T, Mignerey AC, Miki K, Milov A, Mitchell JT, Miyachi Y, Mohanty AK, Moon HJ, Morino Y, Morreale A, Morrison DP, Motschwiller S, Moukhanova TV, Murakami T, Murata J, Nagamiya S, Nagle JL, Naglis M, Nagy MI, Nakagawa I, Nakamiya Y, Nakamura KR, Nakamura T, Nakano K, Nam S, Newby J, Nguyen M, Nihashi M, Nouicer R, Nyanin AS, Oakley C, O'Brien E, Oda SX, Ogilvie CA, Oka M, Okada K, Onuki Y, Oskarsson A, Ouchida M, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park BH, Park IH, Park SK, Park WJ, Pate SF, Patel L, Pei H, Peng JC, Pereira H, Peressounko DY, Petti R, Pinkenburg C, Pisani RP, Proissl M, Purschke ML, Qu H, Rak J, Ravinovich I, Read KF, Rembeczki S, Reygers K, Riabov V, Riabov Y, Richardson E, Roach D, Roche G, Rolnick SD, Rosati M, Rosen CA, Rosendahl SSE, Ružička P, Sahlmueller B, Saito N, Sakaguchi T, Sakashita K, Samsonov V, Sano S, Sarsour M, Sato T, Savastio M, Sawada S, Sedgwick K, Seele J, Seidl R, Seto R, Sharma D, Shein I, Shibata TA, Shigaki K, Shim HH, Shimomura M, Shoji K, Shukla P, Sickles A, Silva CL, Silvermyr D, Silvestre C, Sim KS, Singh BK, Singh CP, Singh V, Slunečka M, Sodre T, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Stankus PW, Stenlund E, Stoll SP, Sugitate T, Sukhanov A, Sun J, Sziklai J, Takagui EM, Takahara A, Taketani A, Tanabe R, Tanaka Y, Taneja S, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Tennant E, Themann H, Thomas D, Thomas TL, Togawa M, Toia A, Tomášek L, Tomášek M, Torii H, Towell RS, Tserruya I, Tsuchimoto Y, Utsunomiya K, Vale C, Valle H, van Hecke HW, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Virius M, Vossen A, Vrba V, Vznuzdaev E, Wang XR, Watanabe D, Watanabe K, Watanabe Y, Watanabe YS, Wei F, Wei R, Wessels J, White SN, Winter D, Woody CL, Wright RM, Wysocki M, Yamaguchi YL, Yamaura K, Yang R, Yanovich A, Ying J, Yokkaichi S, Yoo JS, You Z, Young GR, Younus I, Yushmanov IE, Zajc WA, Zelenski A, Zhou S. Measurement of Long-Range Angular Correlation and Quadrupole Anisotropy of Pions and (Anti)Protons in Central d+Au Collisions at sqrt[s_{NN}]=200 GeV. PHYSICAL REVIEW LETTERS 2015; 114:192301. [PMID: 26024164 DOI: 10.1103/physrevlett.114.192301] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/30/2014] [Indexed: 06/04/2023]
Abstract
We present azimuthal angular correlations between charged hadrons and energy deposited in calorimeter towers in central d+Au and minimum bias p+p collisions at sqrt[s_{NN}]=200 GeV. The charged hadron is measured at midrapidity |η|<0.35, and the energy is measured at large rapidity (-3.7<η<-3.1, Au-going direction). An enhanced near-side angular correlation across |Δη|>2.75 is observed in d+Au collisions. Using the event plane method applied to the Au-going energy distribution, we extract the anisotropy strength v_{2} for inclusive charged hadrons at midrapidity up to p_{T}=4.5 GeV/c. We also present the measurement of v_{2} for identified π^{±} and (anti)protons in central d+Au collisions, and observe a mass-ordering pattern similar to that seen in heavy-ion collisions. These results are compared with viscous hydrodynamic calculations and measurements from p+Pb at sqrt[s_{NN}]=5.02 TeV. The magnitude of the mass ordering in d+Au is found to be smaller than that in p+Pb collisions, which may indicate smaller radial flow in lower energy d+Au collisions.
Collapse
|
87
|
Ienaga K, Nakamura K, Hochi T, Nakazawa Y, Fukunaga Y, Kakita H, Nakano K. Crosslines, fluorophores in the AGE-related cross-linked proteins. CONTRIBUTIONS TO NEPHROLOGY 2015; 112:42-51. [PMID: 7554992 DOI: 10.1159/000424091] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
We can summarize our results as follows: (1) A pair of fluorescent crosslines were isolated from the Maillard reaction mixture; (2) AGE-proteins contained crossline-like structures, and (3) crossline-like immunoreactivities were accumulated in renal tissues of diabetic rats. From these results we concluded that fluorophores in AGE proteins have crossline-like structures and we had the first indication that XLs could be markers for renal disorders.
Collapse
|
88
|
Matsunari H, Watanabe M, Nakano K, Uchikura A, Asano Y, Hatae S, Takeishi T, Umeyama K, Nagaya M, Miyagawa S, Hanazono Y, Nakauchi H, Nagashima H. 31 PRODUCTION EFFICIENCY OF GENE KNOCKOUT PIGS USING GENOME EDITING AND SOMATIC CELL CLONING. Reprod Fertil Dev 2015. [DOI: 10.1071/rdv27n1ab31] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Genome editing technologies have been used as a powerful strategy for the generation of genetically modified pigs. We previously developed genetically modified clone pigs with organogenesis-disabled phenotypes, as well as pigs exhibiting diseases with similar features to those of humans. Here, we report the production efficiency of various gene knockout cloned pigs from somatic cells that were genetically modified using zinc finger nucleases (ZFN) or transcription activator-like effector nucleases (TALEN). The ZFN- or TALEN-encoding mRNAs, which targeted 7 autosomal or X-linked genes, were introduced into porcine fetal fibroblast cells using electroporation. Clonal cell populations carrying induced mutations were selected after limiting dilution. The targeted portion of the genes was amplified using PCR, followed by sequencing and mutation analysis. Among the collected knockout cell colonies, cells showing good proliferation and morphology were selected and used for somatic cell nuclear transfer (SCNT). In vitro-matured oocytes were obtained from porcine cumulus-oocyte complexes cultured in NCSU23-based medium and were used to obtain recipient oocytes for SCNT after enucleation. SCNT was performed as reported previously (Matsunari et al. 2008). The cloned embryos were cultured for 7 days in porcine zygote medium (PZM)-5 to assess their developmental ability. Cloned embryos were transplanted into the oviduct or uterus of oestrus-synchronized recipient gilts to evaluate their competence to develop to fetuses or piglets. Cloned embryos reconstructed with 7 types of knockout cells showed equal development to blastocysts compared with those derived from the wild-type cells (54.5–83.3% v. 60.7%). Our data (Table 1) demonstrated that the reconstructed embryos derived from knockout cells could efficiently give rise to cloned offspring regardless of the type of genome editing methodology (i.e. ZFN or TALEN).
Table 1.Production efficiency of gene knockout cloned pigs using genome editing
This study was supported by JST, ERATO, the Nakauchi Stem Cell and Organ Regeneration Project, JST, CREST, Meiji University International Institute for Bio-Resource Research (MUIIBR), and JSPS KAKENHI Grant Number 26870630.
Collapse
|
89
|
Uchikura A, Matsunari H, Nakano K, Hatae S, Matsumura Y, Asano Y, Takeishi T, Nakauchi H, Nagashima H. 73 APPLICATION OF THE HOLLOW FIBER VITRIFICATION METHOD TO THE CRYOPRESERVATION OF HIGHLY CRYOSENSITIVE EMBRYOS. Reprod Fertil Dev 2015. [DOI: 10.1071/rdv27n1ab73] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
We recently demonstrated that the hollow fibre vitrification (HFV) method (Matsunari et al. 2012) could effectively be applied to the cryopreservation of embryos from diverse species. In this study, we applied the HFV method to the cryopreservation of highly cryosensitive specimens, such as in vitro matured (IVM)/IVF-derived porcine zona-free morulae and blastomeres isolated from those morulae, as well as IVM/IVF-derived cattle embryos at early cleavage stages. Porcine parthenogenetic morulae (d-4) derived from IVM oocytes were treated with 0.25% pronase to remove zona pellucidae. The resulting blastomeres were isolated from the zona-free morulae by a decompaction treatment followed by gentle pipetting. Bovine IVM-IVF embryos at the 2 to 4 cell (d-1), 8 to 16 cell (d-3), and morula stages (d-5) were then subjected to vitrification. The HFV procedure was performed as described previously using 15% dimethyl sulfoxide, 15% ethylene glycol, and 0.5 M trehalose as cryoprotectants. Four to twenty embryos, or all of the blastomeres isolated from a single morula, were individually loaded into a cellulose acetate hollow fibre (25 mm long, 185 μm φ, 15 μm membrane thickness) and vitrified. Survival of the vitrified embryos was assessed by in vitro development to blastocysts. Blastomeres recovered after vitrification were aggregated in micro-wells to examine their ability to form blastocysts. The HFV method was demonstrated to be effective for cryopreserving zona-free in vitro-produced porcine morulae and the blastomeres isolated from them (Table 1), as well as bovine IVM-IVF embryos at early cleavage stages. These data demonstrate that the HFV method is effective for highly cryosensitive specimens, such as IVM/IVF-derived porcine zona-free morulae and blastomeres isolated from those morulae, and IVM/IVF-derived cattle embryos at early cleavage stages. These achievements may expand the technological options in the production of cloned and genetically modified pigs that are useful for biomedical research.
Table 1.Survival of zona-free porcine morulae and isolated blastomeres after vitrification (top) and blastocyst formation rates in bovine early-stage in vitro matured-IVF embryos after vitrification (bottom)
This study was supported by JST, ERATO, the Nakauchi Stem Cell and Organ Regeneration Project, and MUIIBR.
Collapse
|
90
|
Shinkai K, Nakano K, Onishi H, Tanaka M, Katano M. Y-Box Binding Protein-1 is Involved in Tumor Angiogenesis and a Promising Therapeutic Target. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu359.15] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
91
|
Takahashi S, Tahara M, Kiyota N, Yamazaki T, Chayahara N, Nakano K, Inagaki R, Toda K, Enokida T, Minami H, Imamura Y, Sasaki T, Suzuki T, Fujino K, Dutcus C. Phase Ii Study of Lenvatinib (Len), a Multi-Targeted Tyrosine Kinase Inhibitor, in Patients (Pts) with All Histologic Subtypes of Advanced Thyroid Cancer (Differentiated, Medullary and Anaplastic). Ann Oncol 2014. [DOI: 10.1093/annonc/mdu340.10] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
92
|
Harada T, Fukumoto S, Harada M, Nakano K, Sukoh N, Fuke S, Asahina H, Takamura K, Yamamoto M, Fujita Y, Akie K, Kinoshita I, Oizumi S, Akita H, Isobe H, Nishimura M. A Randomized Phase Ii Trial of Cisplatin Plus Gemcitabine Versus Carboplatin Plus Gemcitabine in Patients with Completely Resected Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (Hot0703). Ann Oncol 2014. [DOI: 10.1093/annonc/mdu347.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
93
|
Adare A, Afanasiev S, Aidala C, Ajitanand N, Akiba Y, Al-Bataineh H, Alexander J, Angerami A, Aoki K, Apadula N, Aphecetche L, Aramaki Y, Asai J, Atomssa E, Averbeck R, Awes T, Azmoun B, Babintsev V, Bai M, Baksay G, Baksay L, Baldisseri A, Barish K, Barnes P, Bassalleck B, Basye A, Bathe S, Batsouli S, Baublis V, Baumann C, Bazilevsky A, Belikov S, Belmont R, Bennett R, Berdnikov A, Berdnikov Y, Bhom J, Bickley A, Blau D, Boissevain J, Bok J, Borel H, Boyle K, Brooks M, Buesching H, Bumazhnov V, Bunce G, Butsyk S, Camacho C, Campbell S, Caringi A, Chang B, Chang W, Charvet JL, Chen CH, Chernichenko S, Chi C, Chiu M, Choi I, Choi J, Choudhury R, Christiansen P, Chujo T, Chung P, Churyn A, Chvala O, Cianciolo V, Citron Z, Cole B, Conesa del Valle Z, Connors M, Constantin P, Csanád M, Csörgő T, Dahms T, Dairaku S, Danchev I, Das K, Datta A, David G, Dayananda M, Denisov A, d’Enterria D, Deshpande A, Desmond E, Dharmawardane K, Dietzsch O, Dion A, Donadelli M, Drapier O, Drees A, Drees K, Dubey A, Durham J, Durum A, Dutta D, Dzhordzhadze V, D’Orazio L, Edwards S, Efremenko Y, Ellinghaus F, Engelmore T, Enokizono A, En’yo H, Esumi S, Eyser K, Fadem B, Feege N, Fields D, Finger M, Finger M, Fleuret F, Fokin S, Fraenkel Z, Frantz J, Franz A, Frawley A, Fujiwara K, Fukao Y, Fusayasu T, Garishvili I, Glenn A, Gong H, Gonin M, Gosset J, Goto Y, Granier de Cassagnac R, Grau N, Greene S, Grim G, Grosse Perdekamp M, Gunji T, Gustafsson HÅ, Hadj Henni A, Haggerty J, Hahn K, Hamagaki H, Hamblen J, Han R, Hanks J, Hartouni E, Haruna K, Haslum E, Hayano R, He X, Heffner M, Hemmick T, Hester T, Hill J, Hohlmann M, Holzmann W, Homma K, Hong B, Horaguchi T, Hornback D, Huang S, Ichihara T, Ichimiya R, Iinuma H, Ikeda Y, Imai K, Imrek J, Inaba M, Isenhower D, Ishihara M, Isobe T, Issah M, Isupov A, Ivanischev D, Iwanaga Y, Jacak B, Jia J, Jiang X, Jin J, Johnson B, Jones T, Joo K, Jouan D, Jumper D, Kajihara F, Kametani S, Kamihara N, Kamin J, Kang J, Kapustinsky J, Karatsu K, Kasai M, Kawall D, Kawashima M, Kazantsev A, Kempel T, Khanzadeev A, Kijima K, Kikuchi J, Kim A, Kim B, Kim D, Kim D, Kim E, Kim EJ, Kim S, Kim YJ, Kinney E, Kiriluk K, Kiss Á, Kistenev E, Klay J, Klein-Boesing C, Kleinjan D, Kochenda L, Komkov B, Konno M, Koster J, Kozlov A, Král A, Kravitz A, Kunde G, Kurita K, Kurosawa M, Kweon M, Kwon Y, Kyle G, Lacey R, Lai Y, Lajoie J, Layton D, Lebedev A, Lee D, Lee J, Lee K, Lee K, Lee T, Leitch M, Leite M, Lenzi B, Li X, Lichtenwalner P, Liebing P, Linden Levy L, Liška T, Litvinenko A, Liu H, Liu M, Love B, Lynch D, Maguire C, Makdisi Y, Malakhov A, Malik M, Manko V, Mannel E, Mao Y, Mašek L, Masui H, Matathias F, McCumber M, McGaughey P, McGlinchey D, Means N, Meredith B, Miake Y, Mibe T, Mignerey A, Mikeš P, Miki K, Milov A, Mishra M, Mitchell J, Mohanty A, Moon H, Morino Y, Morreale A, Morrison D, Moukhanova T, Mukhopadhyay D, Murakami T, Murata J, Nagamiya S, Nagle J, Naglis M, Nagy M, Nakagawa I, Nakamiya Y, Nakamura K, Nakamura T, Nakano K, Nam S, Newby J, Nguyen M, Nihashi M, Niida T, Nouicer R, Nyanin A, Oakley C, O’Brien E, Oda S, Ogilvie C, Oka M, Okada K, Onuki Y, Oskarsson A, Ouchida M, Ozawa K, Pak R, Palounek A, Pantuev V, Papavassiliou V, Park I, Park J, Park S, Park W, Pate S, Pei H, Peng JC, Pereira H, Peresedov V, Peressounko D, Petti R, Pinkenburg C, Pisani R, Proissl M, Purschke M, Purwar A, Qu H, Rak J, Rakotozafindrabe A, Ravinovich I, Read K, Rembeczki S, Reygers K, Riabov V, Riabov Y, Richardson E, Roach D, Roche G, Rolnick S, Rosati M, Rosen C, Rosendahl S, Rosnet P, Rukoyatkin P, Ružička P, Rykov V, Sahlmueller B, Saito N, Sakaguchi T, Sakai S, Sakashita K, Samsonov V, Sano S, Sato T, Sawada S, Sedgwick K, Seele J, Seidl R, Semenov A, Semenov V, Seto R, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shoji K, Shukla P, Sickles A, Silva C, Silvermyr D, Silvestre C, Sim K, Singh B, Singh C, Singh V, Slunečka M, Soldatov A, Soltz R, Sondheim W, Sorensen S, Sourikova I, Staley F, Stankus P, Stenlund E, Stepanov M, Ster A, Stoll S, Sugitate T, Suire C, Sukhanov A, Sziklai J, Takagui E, Taketani A, Tanabe R, Tanaka Y, Taneja S, Tanida K, Tannenbaum M, Tarafdar S, Taranenko A, Tarján P, Themann H, Thomas D, Thomas T, Togawa M, Toia A, Tomášek L, Tomita Y, Torii H, Towell R, Tram VN, Tserruya I, Tsuchimoto Y, Vale C, Valle H, van Hecke H, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Vinogradov A, Virius M, Vossen A, Vrba V, Vznuzdaev E, Wang X, Watanabe D, Watanabe K, Watanabe Y, Wei F, Wei R, Wessels J, White S, Winter D, Woody C, Wright R, Wysocki M, Xie W, Yamaguchi Y, Yamaura K, Yang R, Yanovich A, Ying J, Yokkaichi S, You Z, Young G, Younus I, Yushmanov I, Zajc W, Zaudtke O, Zhang C, Zhou S, Zolin L. Measurement of transverse-single-spin asymmetries for midrapidity and forward-rapidity production of hadrons in polarizedp+pcollisions ats=200and 62.4 GeV. Int J Clin Exp Med 2014. [DOI: 10.1103/physrevd.90.012006] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
94
|
Adare A, Aidala C, Ajitanand NN, Akiba Y, Akimoto R, Al-Bataineh H, Al-Ta'ani H, Alexander J, Andrews KR, Angerami A, Aoki K, Apadula N, Appelt E, Aramaki Y, Armendariz R, Aschenauer EC, Atomssa ET, Averbeck R, Awes TC, Azmoun B, Babintsev V, Bai M, Baksay G, Baksay L, Bannier B, Barish KN, Bassalleck B, Basye AT, Bathe S, Baublis V, Baumann C, Bazilevsky A, Belikov S, Belmont R, Ben-Benjamin J, Bennett R, Bhom JH, Blau DS, Bok JS, Boyle K, Brooks ML, Broxmeyer D, Buesching H, Bumazhnov V, Bunce G, Butsyk S, Campbell S, Caringi A, Castera P, Chen CH, Chi CY, Chiu M, Choi IJ, Choi JB, Choudhury RK, Christiansen P, Chujo T, Chung P, Chvala O, Cianciolo V, Citron Z, Cole BA, Conesa Del Valle Z, Connors M, Csanád M, Csörgő T, Dahms T, Dairaku S, Danchev I, Das K, Datta A, David G, Dayananda MK, Denisov A, Deshpande A, Desmond EJ, Dharmawardane KV, Dietzsch O, Dion A, Donadelli M, Drapier O, Drees A, Drees KA, Durham JM, Durum A, Dutta D, D'Orazio L, Edwards S, Efremenko YV, Ellinghaus F, Engelmore T, Enokizono A, En'yo H, Esumi S, Fadem B, Fields DE, Finger M, Finger M, Fleuret F, Fokin SL, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fujiwara K, Fukao Y, Fusayasu T, Gal C, Garishvili I, Glenn A, Gong H, Gong X, Gonin M, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grim G, Grosse Perdekamp M, Gunji T, Guo L, Gustafsson HÅ, Haggerty JS, Hahn KI, Hamagaki H, Hamblen J, Han R, Hanks J, Harper C, Hashimoto K, Haslum E, Hayano R, He X, Heffner M, Hemmick TK, Hester T, Hill JC, Hohlmann M, Hollis RS, Holzmann W, Homma K, Hong B, Horaguchi T, Hori Y, Hornback D, Huang S, Ichihara T, Ichimiya R, Iinuma H, Ikeda Y, Imai K, Inaba M, Iordanova A, Isenhower D, Ishihara M, Issah M, Ivanischev D, Iwanaga Y, Jacak BV, Jia J, Jiang X, Jin J, John D, Johnson BM, Jones T, Joo KS, Jouan D, Jumper DS, Kajihara F, Kamin J, Kaneti S, Kang BH, Kang JH, Kang JS, Kapustinsky J, Karatsu K, Kasai M, Kawall D, Kawashima M, Kazantsev AV, Kempel T, Khanzadeev A, Kijima KM, Kikuchi J, Kim A, Kim BI, Kim DJ, Kim EJ, Kim YJ, Kim YK, Kinney E, Kiss A, Kistenev E, Kleinjan D, Kline P, Kochenda L, Komkov B, Konno M, Koster J, Kotov D, Král A, Kravitz A, Kunde GJ, Kurita K, Kurosawa M, Kwon Y, Kyle GS, Lacey R, Lai YS, Lajoie JG, Lebedev A, Lee DM, Lee J, Lee KB, Lee KS, Lee SH, Lee SR, Leitch MJ, Leite MAL, Li X, Lichtenwalner P, Liebing P, Lim SH, Linden Levy LA, Liška T, Liu H, Liu MX, Love B, Lynch D, Maguire CF, Makdisi YI, Malik MD, Manion A, Manko VI, Mannel E, Mao Y, Masui H, Matathias F, McCumber M, McGaughey PL, McGlinchey D, McKinney C, Means N, Mendoza M, Meredith B, Miake Y, Mibe T, Mignerey AC, Miki K, Milov A, Mitchell JT, Miyachi Y, Mohanty AK, Moon HJ, Morino Y, Morreale A, Morrison DP, Motschwiller S, Moukhanova TV, Murakami T, Murata J, Nagamiya S, Nagle JL, Naglis M, Nagy MI, Nakagawa I, Nakamiya Y, Nakamura KR, Nakamura T, Nakano K, Nam S, Newby J, Nguyen M, Nihashi M, Nouicer R, Nyanin AS, Oakley C, O'Brien E, Oda SX, Ogilvie CA, Oka M, Okada K, Onuki Y, Oskarsson A, Ouchida M, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park BH, Park IH, Park SK, Park WJ, Pate SF, Patel L, Pei H, Peng JC, Pereira H, Peressounko DY, Petti R, Pinkenburg C, Pisani RP, Proissl M, Purschke ML, Qu H, Rak J, Ravinovich I, Read KF, Rembeczki S, Reygers K, Riabov V, Riabov Y, Richardson E, Roach D, Roche G, Rolnick SD, Rosati M, Rosen CA, Rosendahl SSE, Ružička P, Sahlmueller B, Saito N, Sakaguchi T, Sakashita K, Samsonov V, Sano S, Sarsour M, Sato T, Savastio M, Sawada S, Sedgwick K, Seele J, Seidl R, Seto R, Sharma D, Shein I, Shibata TA, Shigaki K, Shim HH, Shimomura M, Shoji K, Shukla P, Sickles A, Silva CL, Silvermyr D, Silvestre C, Sim KS, Singh BK, Singh CP, Singh V, Slunečka M, Sodre T, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Stankus PW, Stenlund E, Stoll SP, Sugitate T, Sukhanov A, Sun J, Sziklai J, Takagui EM, Takahara A, Taketani A, Tanabe R, Tanaka Y, Taneja S, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Tennant E, Themann H, Thomas D, Thomas TL, Togawa M, Toia A, Tomášek L, Tomášek M, Torii H, Towell RS, Tserruya I, Tsuchimoto Y, Utsunomiya K, Vale C, Valle H, van Hecke HW, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Virius M, Vossen A, Vrba V, Vznuzdaev E, Wang XR, Watanabe D, Watanabe K, Watanabe Y, Watanabe YS, Wei F, Wei R, Wessels J, White SN, Winter D, Woody CL, Wright RM, Wysocki M, Yamaguchi YL, Yamaura K, Yang R, Yanovich A, Ying J, Yokkaichi S, Yoo JS, You Z, Young GR, Younus I, Yushmanov IE, Zajc WA, Zelenski A, Zhou S. Cold-nuclear-matter effects on heavy-quark production at forward and backward rapidity in d + Au collisions at √sNN = 200 GeV. PHYSICAL REVIEW LETTERS 2014; 112:252301. [PMID: 25014805 DOI: 10.1103/physrevlett.112.252301] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/03/2013] [Indexed: 06/03/2023]
Abstract
The PHENIX experiment has measured open heavy-flavor production via semileptonic decay over the transverse momentum range 1 < p(T) < 6 GeV/c at forward and backward rapidity (1.4 < |y| < 2.0) in d+Au and p + p collisions at √sNN = 200 GeV. In central d+Au collisions, relative to the yield in p + p collisions scaled by the number of binary nucleon-nucleon collisions, a suppression is observed at forward rapidity (in the d-going direction) and an enhancement at backward rapidity (in the Au-going direction). Predictions using nuclear-modified-parton-distribution functions, even with additional nuclear-p(T) broadening, cannot simultaneously reproduce the data at both rapidity ranges, which implies that these models are incomplete and suggests the possible importance of final-state interactions in the asymmetric d + Au collision system. These results can be used to probe cold-nuclear-matter effects, which may significantly affect heavy-quark production, in addition to helping constrain the magnitude of charmonia-breakup effects in nuclear matter.
Collapse
|
95
|
Adare A, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Al-Bataineh H, Alexander J, Aoki K, Aramaki Y, Atomssa ET, Averbeck R, Awes TC, Azmoun B, Babintsev V, Bai M, Baksay G, Baksay L, Barish KN, Bassalleck B, Basye AT, Bathe S, Baublis V, Baumann C, Bazilevsky A, Belikov S, Belmont R, Bennett R, Berdnikov A, Berdnikov Y, Bickley AA, Bok JS, Boyle K, Brooks ML, Buesching H, Bumazhnov V, Bunce G, Butsyk S, Camacho CM, Campbell S, Chen CH, Chi CY, Chiu M, Choi IJ, Choudhury RK, Christiansen P, Chujo T, Chung P, Chvala O, Cianciolo V, Citron Z, Cole BA, Connors M, Constantin P, Csanád M, Csörgő T, Dahms T, Dairaku S, Danchev I, Das K, Datta A, David G, Denisov A, Deshpande A, Desmond EJ, Dietzsch O, Dion A, Donadelli M, Drapier O, Drees A, Drees KA, Durham JM, Durum A, Dutta D, Edwards S, Efremenko YV, Ellinghaus F, Engelmore T, Enokizono A, En'yo H, Esumi S, Fadem B, Fields DE, Finger M, Finger M, Fleuret F, Fokin SL, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fujiwara K, Fukao Y, Fusayasu T, Garishvili I, Glenn A, Gong H, Gonin M, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grosse Perdekamp M, Gunji T, Gustafsson HÅ, Haggerty JS, Hahn KI, Hamagaki H, Hamblen J, Han R, Hanks J, Hartouni EP, Haslum E, Hayano R, He X, Heffner M, Hemmick TK, Hester T, Hill JC, Hohlmann M, Holzmann W, Homma K, Hong B, Horaguchi T, Hornback D, Huang S, Ichihara T, Ichimiya R, Ide J, Ikeda Y, Imai K, Inaba M, Isenhower D, Ishihara M, Isobe T, Issah M, Isupov A, Ivanischev D, Jacak BV, Jia J, Jin J, Johnson BM, Joo KS, Jouan D, Jumper DS, Kajihara F, Kametani S, Kamihara N, Kamin J, Kang JH, Kapustinsky J, Karatsu K, Kawall D, Kawashima M, Kazantsev AV, Kempel T, Khanzadeev A, Kijima KM, Kim BI, Kim DH, Kim DJ, Kim E, Kim EJ, Kim SH, Kim YJ, Kinney E, Kiriluk K, Kiss A, Kistenev E, Kochenda L, Komkov B, Konno M, Koster J, Kotchetkov D, Kozlov A, Král A, Kravitz A, Kunde GJ, Kurita K, Kurosawa M, Kwon Y, Kyle GS, Lacey R, Lai YS, Lajoie JG, Lebedev A, Lee DM, Lee J, Lee K, Lee KB, Lee KS, Leitch MJ, Leite MAL, Leitner E, Lenzi B, Li X, Liebing P, Linden Levy LA, Liška T, Litvinenko A, Liu H, Liu MX, Love B, Luechtenborg R, Lynch D, Maguire CF, Makdisi YI, Malakhov A, Malik MD, Manko VI, Mannel E, Mao Y, Masui H, Matathias F, McCumber M, McGaughey PL, Means N, Meredith B, Miake Y, Mignerey AC, Mikeš P, Miki K, Milov A, Mishra M, Mitchell JT, Mohanty AK, Morino Y, Morreale A, Morrison DP, Moukhanova TV, Murata J, Nagamiya S, Nagle JL, Naglis M, Nagy MI, Nakagawa I, Nakamiya Y, Nakamura T, Nakano K, Newby J, Nguyen M, Niida T, Nouicer R, Nyanin AS, O'Brien E, Oda SX, Ogilvie CA, Oka M, Okada K, Onuki Y, Oskarsson A, Ouchida M, Ozawa K, Pak R, Pantuev V, Papavassiliou V, Park IH, Park J, Park SK, Park WJ, Pate SF, Pei H, Peng JC, Pereira H, Peresedov V, Peressounko DY, Pinkenburg C, Pisani RP, Proissl M, Purschke ML, Purwar AK, Qu H, Rak J, Rakotozafindrabe A, Ravinovich I, Read KF, Reygers K, Riabov V, Riabov Y, Richardson E, Roach D, Roche G, Rolnick SD, Rosati M, Rosen CA, Rosendahl SSE, Rosnet P, Rukoyatkin P, Ružička P, Sahlmueller B, Saito N, Sakaguchi T, Sakashita K, Samsonov V, Sano S, Sato T, Sawada S, Sedgwick K, Seele J, Seidl R, Semenov AY, Seto R, Sharma D, Shein I, Shibata TA, Shigaki K, Shimomura M, Shoji K, Shukla P, Sickles A, Silva CL, Silvermyr D, Silvestre C, Sim KS, Singh BK, Singh CP, Singh V, Slunečka M, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Sparks NA, Stankus PW, Stenlund E, Stoll SP, Sugitate T, Sukhanov A, Sziklai J, Takagui EM, Taketani A, Tanabe R, Tanaka Y, Tanida K, Tannenbaum MJ, Tarafdar S, Taranenko A, Tarján P, Themann H, Thomas TL, Todoroki T, Togawa M, Toia A, Tomášek L, Torii H, Towell RS, Tserruya I, Tsuchimoto Y, Vale C, Valle H, van Hecke HW, Vazquez-Zambrano E, Veicht A, Velkovska J, Vértesi R, Vinogradov AA, Virius M, Vrba V, Vznuzdaev E, Wang XR, Watanabe D, Watanabe K, Watanabe Y, Wei F, Wei R, Wessels J, White SN, Winter D, Wood JP, Woody CL, Wright RM, Wysocki M, Xie W, Yamaguchi YL, Yamaura K, Yang R, Yanovich A, Ying J, Yokkaichi S, You Z, Young GR, Younus I, Yushmanov IE, Zajc WA, Zhang C, Zhou S, Zolin L. Azimuthal-angle dependence of charged-pion-interferometry measurements with respect to second- and third-order event planes in Au+Au collisions at √[S(NN)]=200 GeV. PHYSICAL REVIEW LETTERS 2014; 112:222301. [PMID: 24949761 DOI: 10.1103/physrevlett.112.222301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2014] [Indexed: 06/03/2023]
Abstract
Charged-pion-interferometry measurements were made with respect to the second- and third-order event plane for Au+Au collisions at sqrt[s_{NN}]=200 GeV. A strong azimuthal-angle dependence of the extracted Gaussian-source radii was observed with respect to both the second- and third-order event planes. The results for the second-order dependence indicate that the initial eccentricity is reduced during the medium evolution, which is consistent with previous results. In contrast, the results for the third-order dependence indicate that the initial triangular shape is significantly reduced and potentially reversed by the end of the medium evolution, and that the third-order oscillations are largely dominated by the dynamical effects from triangular flow.
Collapse
|
96
|
Kido A, Akahane M, Hara R, Shimizu T, Nakano K, Kobata Y, Fujimura T, Shinmyo N, Akai Y, Fujimoto T, Tanaka Y. AB0802 A Patients Preference Survey for Osteoporosis Medication on 679 Patients: Monthly Drug Regimen Can be the Best for the Adherence. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.1628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
97
|
Tanaka Y, Hirata S, Kubo S, Fukuyo S, Hanami K, Sawamukai N, Nakano K, Nakayamada S, Yamaoka K, Saito K. AB0415 A New Prognostic Factor to Sustain Remission for 2 Years after Adalimumab Discontinuation & the Clinical Outcomes in RA Patients: Honor Study 2-Years Results. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.4002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
98
|
Kondo M, Yamaoka K, Sonomoto K, Nakano K, Tanaka Y. SAT0568 IL-6-Stat3-Signaling Enhances Chondrogenic Differentiation of Human Mesenchymal Stem Cells. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.3959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
99
|
Saito K, Miyagawa I, Yamaoka K, Nakayamada S, Nakano K, Hirata S, Fukuyo S, Kubo S, Hanami K, Sawamukai N, Tanaka Y. FRI0474 The Three-Year Outcome of Infliximab (IFX), an Anti-TNF-α Antibody, in Patients with Refractory Intestinal-BehÇEt's Disease (BD). Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2014-eular.2805] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
100
|
Nakano K, Moriyama T, Yasuda K, Shibuya H, Tajima T, Shigematsu A, Shimizu C. Identification of IgG-κ type macroprolactin found in the serum of an 8-year-old girl. Clin Chim Acta 2014; 433:206-8. [DOI: 10.1016/j.cca.2014.03.019] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2013] [Revised: 03/17/2014] [Accepted: 03/19/2014] [Indexed: 11/30/2022]
|